Ace Therapeutics is an expert in the field of liver disease. Our goal is to provide the most advanced and comprehensive vaccine development platform for liver disease researchers.
Advanced vaccine development platforms are essential for the development and exploitation of liver disease vaccines. We offer a comprehensive platform to meet the research needs of different investigators.
What Can We Do?
We offer a comprehensive vaccine development service that incorporates the characteristics of liver disease.
- Vaccine Development Platform for Viral Hepatitis
The development of viral vaccines is crucial in the field of prevention and control of viral disease infections. With the development of technology, the types of vaccines are becoming more and more available. We offer different research services for the development of hepatitis virus vaccines, including but not limited to
- Inactivated virus vaccine development platform
Inactivated virus vaccines are the most mature vaccine development technology. Our inactivated virus vaccine development platform has developed vaccines with excellent performance in terms of stability and safety.
- Live attenuated vaccine development platform
We have effectively reduced the pathogenicity of viruses through cell culture passaging to make them available for vaccine production. We have developed different methods to enhance the safety of live attenuated vaccines.
- Subunit vaccine development platform
In subunit vaccine development, we induce antibody responses in CD4+ Th cells to provide protection. Our subunit vaccine development platform has a mature development process, is safe, and can be produced at scale.
- Virus-like particle vaccine development platform
We have constructed different bacterial expression systems, yeast expression systems, and cell line expression systems for the production of virus-like particles.
In addition, we have a recombinant virus vector vaccine development platform and a nucleic acid vaccine development platform to meet the needs of different research.
- Vaccine Development Platform for Liver Cancer
Cancer vaccines can be an effective way to treat cancer by amplifying tumor-specific T-cell responses through active immunity. Liver cancer vaccines are currently demonstrating significant therapeutic efficacy. In view of this, we provide a comprehensive technology platform to support the development and exploitation of liver cancer vaccines.
- Cell-based vaccine development platform
We provide tumor cell vaccine and immune cell vaccine development. We have established different modification methods to improve the immunogenicity and thus the efficacy of cellular vaccines.
- Virus-based vaccine development platform
On the one hand, we provide tumor vaccine development services based on vectors such as lysoviruses, adenoviruses, cowpox viruses, and lentiviral adeno-associated viruses. On the other hand, we provide a platform for vaccine development against tumor-causing viruses.
- Peptide-based cancer vaccine development platform
We provide cancer vaccine development services based on peptides composed of known or predicted tumor antigen epitopes. We also provide adjuvant screening services to enhance the immunogenicity of different peptides depending on their nature and vaccine development process.
- Nucleic acid-based cancer vaccine development platform
Our nucleic acid-based cancer vaccine development platform covers both DNA and RNA vaccines. We also provide different optimization strategies to enhance the efficacy of nucleic acid-based cancer vaccines.
Based on our rich hands-on experience and advanced vaccine platform, Ace Therapeutics is committed to providing you with high-quality and efficient vaccine development services for liver diseases. If you would like to learn more about our services, please feel free to contact us.
Our products and services are for research use only and can not be used for diagnostic or other purposes.
